Fig 1: Neuropathic pain and treatment alter the hippocampal level of glutamate receptors and PSD-95. (a) Production of NMDAR1 (NR1) in ipsilateral hippocampus, optical density units, %. (b) Production of NMDAR1 (NR1) in contralateral hippocampus, optical density units, %. (c) Production of GluA1 in ipsilateral hippocampus, optical density units, %. (d) Production of GluA1 in contralateral hippocampus, optical density units, %. (e) Production of GluA2 in ipsilateral hippocampus, optical density units, %. (f) Production of GluA2 in contralateral hippocampus, optical density units, %. (g) Production of PSD-95 in ipsilateral hippocampus, optical density units, %. (h) Production of PSD-95 in contralateral hippocampus, optical density units, %., * p < 0.05, ** p < 0.01; + p < 0.05, ++ p < 0.01. *-compared to Veh, +-compared to LPS.